Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Michael Paul Cancro, Ph.D.

Michael Paul Cancro, Ph.D.

faculty photo
Professor of Pathology and Laboratory Medicine
Department: Pathology and Laboratory Medicine
Graduate Group Affiliations

Contact information
284 John Morgan Building
3620 Hamilton Walk
Philadelphia, PA 19104
Office: (215) 898-8067
Fax: (215) 573-2350
Education:
B.S. (Zoology)
University of Maryland College Park, 1973.
Ph.D. (Zoology/Genetics)
University of Maryland College Park, 1976.
Postdoc (Immunology)
University of Pennsylvania, 1977.
Permanent link
 
School of Medicine > Faculty > Search

Description of Research Expertise

Research Interests

B lymphocyte development, selection, and homeostasis; immunobiology of aging.

Research Summary

The size and makeup of mature B cell compartments is controlled by the proportion of immature B cells that complete differentiation, coupled with the average lifespan of mature B cells. Determining the selective and homeostatic factors controlling these parameters is thus key to understanding how the B cell repertoire is established and maintained. Our previous work defined the developmental stages spanning immature B cell formation in the marrow and final maturation in the periphery. More recently, we have focused on the molecular basis for survival and differentiation within these developmental subsets, with emphasis on the role of BLyS and BLyS receptors. Through developmental and kinetic studies in normal and mutant mice, we have found that BLyS controls peripheral B cell numbers in two ways: by varying the proportion of cells that complete transitional B cell development, and by serving as the primary determinant of mature follicular B cell lifespan. Ongoing studies are aimed at determining the molecular and cellular mechanism of BLyS activity in these subsets, as well as how BLyS responsiveness is integrated with BCR signaling. Additionally, we have begun studies of how these selective and homeostatic processes change with age. Our results indicate that the size and dynamics of most B cell subsets shift with age, suggesting age-associated alterations in both intrinsic and microenvironmental factors that govern these processes.

Selected Publications

Goenka R, Barnett LG, Silver JS, O’Neill PJ, Hunter CA, Cancro MP, Laufer, TM.: Cutting Edge: Dendritic cell-restricted antigen presentation initiates the follicular Th cell program but cannot complete ultimate effector differentiation. J Immunol. 187(3): 1091-5, August 2011 Notes: [Epub ahead of print: 29 Jun 2011]

Hao Y, O’Neill P, Naradikian MS, Scholz JL, Cancro MP : A B cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood 118(5): 1294-304, August 2011 Notes: [Epub ahead of print: 11 May 2011]

Parsons RF, Vivek K, Rostami SY, Zekavat G, Ziaie SM, Luo Y, Koeberlein B, Redfield RR, Cancro MP, Naji A, and Noorchashm H.: Acquisition of humoral transplantation tolerance upon de novo emergence of B lymphocytes. J Immunol. 186(1): 614-20, January 2011.

Stumhofer JS, Tait ED, Quinn WJ 3rd, Hosken N, Spudy B, Goenka R, Fielding CA, O'Hara AC, Chen Y, Jones ML, Saris CJ, Rose-John S, Cua DJ, Jones SA, Elloso MM, Grötzinger J, Cancro MP, Levin SD, Hunter CA. : A role for IL-27p28 as an antagonist of gp130-mediated signaling Nat Immunol. 11(12): 1119-1126, December 2010.

Shahaf G, Cancro MP, Mehr R.: Kinetic modeling reveals a common death niche for newly formed and mature B cells. PLoS One 5(3): e9497, March 2010.

Zhu P, Liu X, Treml LS, Cancro MP, Freedman BD.: Mechanism and regulatory function of CpG signaling via scavenger receptor B1 in primary B cells. J. Biol. Chem. 284(34): 22878-87, August 2009.

Crowley JE, Stadanlick JE, Cambier JC, Cancro MP.: Fcγ RIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor upregulation. Blood 113: 1464-1473, February 2009.

Zekavat G, Rostami SY, Badkerhanian A, Parsons RF, Koeberlein B, Yu M, Ward CD, Migone TS, Yu L, Eisenbarth GS, Cancro MP, Naji A, Noorchashm H.: In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice. J. Immunol. 181(11): 8133-8144, December 2008.

Stadanlick JE, Kaileh M, Karnell FG, Scholz JL, Miller JP, Quinn WJ 3rd, Brezski RJ, Treml LS, Jordan KA, Monroe JG, Sen R, Cancro MP: Tonic B cell antigen receptor signals supply an NFkB substrate for prosurvival BLyS signaling. Nat Immunol. 9(12): 1379-1387, December 2008.

Scholz JL, Crowley JE, Tomayko MM, Steinel N, O'Neill PJ, Quinn WJ 3rd, Goenka R, Miller JP, Cho YH, Long V, Ward C, Migone TS, Shlomchik MJ, Cancro MP.: BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact. Proc Natl Acad Sci USA 105: 15517-15522, October 2008 Notes: [published ahead of print 1 October 2008]

back to top
Last updated: 02/01/2012
The Trustees of the University of Pennsylvania